These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38802026)

  • 1. Effect of hydrogel drug delivery system for treating ulcerative colitis: A preclinical meta-analysis.
    Jiang L; Li J; Yang R; Chen S; Wu Y; Jin Y; Wang J; Weng Q; Wang J
    Int J Pharm; 2024 Jun; 659():124281. PubMed ID: 38802026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
    Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
    Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.
    You YC; Dong LY; Dong K; Xu W; Yan Y; Zhang L; Wang K; Xing FJ
    Carbohydr Polym; 2015 Oct; 130():243-53. PubMed ID: 26076623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive and thermosensitive Bletilla striata polysaccharide/chitosan hydrogel loaded nanoparticles for rectal drug delivery in ulcerative colitis.
    Zhao S; Zhang J; Qiu M; Hou Y; Li X; Zhong G; Gou K; Li J; Zhang C; Qu Y; Wang X
    Int J Biol Macromol; 2024 Jan; 254(Pt 1):127761. PubMed ID: 38287598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-Adhering Delivery System with Inflammation Responsiveness for Localized Therapy of Experimental Colitis.
    Kumar A; Kanika ; Kumar V; Ahmad A; Mishra RK; Nadeem A; Siddiqui N; Ansari MM; Raza SS; Kondepudi KK; Khan R
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4781-4793. PubMed ID: 37497615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH; Abu-Risha SE
    Fundam Clin Pharmacol; 2021 Feb; 35(1):143-155. PubMed ID: 32383169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring Mucosal Barrier Function and Modifying Macrophage Phenotype with an Extracellular Matrix Hydrogel: Potential Therapy for Ulcerative Colitis.
    Keane TJ; Dziki J; Sobieski E; Smoulder A; Castleton A; Turner N; White LJ; Badylak SF
    J Crohns Colitis; 2017 Mar; 11(3):360-368. PubMed ID: 27543807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice.
    Bai XY; Yan Y; Wang L; Zhao LG; Wang K
    Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive hydrogel for rectal perfusion improved the therapeutic effect of Kangfuxin liquid on DSS-induced ulcerative colitis mice: The inflammation alleviation and the colonic mucosal barriers repair.
    Xue P; Wang L; Xu J; Liu J; Pan X; Zhao Y; Xu H
    Int J Pharm; 2020 Nov; 589():119846. PubMed ID: 32891717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel-metal-organic-framework hybrids mediated efficient oral delivery of siRNA for the treatment of ulcerative colitis.
    Gao M; Yang C; Wu C; Chen Y; Zhuang H; Wang J; Cao Z
    J Nanobiotechnology; 2022 Sep; 20(1):404. PubMed ID: 36064365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
    Xu W; Su W; Xue Z; Pu F; Xie Z; Jin K; Polyakov NE; Dushkin AV; Su W
    Pharm Res; 2021 Apr; 38(4):693-706. PubMed ID: 33754258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis.
    Luo JY; Zhong Y; Cao JC; Cui HF
    Biomed Pharmacother; 2011 Mar; 65(2):111-7. PubMed ID: 21227626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.
    Sohail M; Mudassir ; Minhas MU; Khan S; Hussain Z; de Matas M; Shah SA; Khan S; Kousar M; Ullah K
    Drug Deliv Transl Res; 2019 Apr; 9(2):595-614. PubMed ID: 29611113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.
    Zhao Y; Xue P; Lin G; Tong M; Yang J; Zhang Y; Ran K; Zhuge D; Yao Q; Xu H
    Acta Biomater; 2022 Apr; 143():233-252. PubMed ID: 35245681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with
    Zhang L; Gui S; Xu Y; Zeng J; Wang J; Chen Q; Su L; Wang Z; Deng R; Chu F; Liu W; Jin X; Lu X
    Theranostics; 2021; 11(7):3417-3438. PubMed ID: 33537095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile Types of Polysaccharide-Based Drug Delivery Systems: From Strategic Design to Cancer Therapy.
    Sun Y; Jing X; Ma X; Feng Y; Hu H
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis.
    Zu M; Song H; Zhang J; Chen Q; Deng S; Canup BSB; Yuan Y; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110747. PubMed ID: 31924469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.